A detailed history of Tcg Advisory Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tcg Advisory Services, LLC holds 20,599 shares of LLY stock, worth $16.1 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
20,599
Previous 7,334 180.87%
Holding current value
$16.1 Million
Previous $6.64 Million 174.83%
% of portfolio
0.82%
Previous 0.33%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $10.2 Million - $12.7 Million
13,265 Added 180.87%
20,599 $18.2 Million
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $892,314 - $1.12 Million
1,231 Added 20.17%
7,334 $6.64 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $826,119 - $1.11 Million
1,395 Added 29.63%
6,103 $4.75 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $709,531 - $836,444
1,351 Added 40.24%
4,708 $2.74 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $49,555 - $68,320
-114 Reduced 3.28%
3,357 $1.8 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $37,178 - $49,711
106 Added 3.15%
3,471 $1.63 Million
Q1 2023

Apr 24, 2023

BUY
$310.63 - $364.82 $119,903 - $140,820
386 Added 12.96%
3,365 $1.16 Million
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $113,185 - $131,883
352 Added 13.4%
2,979 $1.09 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $292,032 - $332,801
985 Added 59.99%
2,627 $850,000
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $217,409 - $255,270
-780 Reduced 32.2%
1,642 $532,000
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $141,518 - $175,870
603 Added 33.15%
2,422 $693,000
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $14,390 - $17,858
64 Added 3.65%
1,819 $502,000
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $7,312 - $8,999
33 Added 1.92%
1,755 $406,000
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $310,907 - $402,155
1,722 New
1,722 $395,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tcg Advisory Services, LLC Portfolio

Follow Tcg Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Advisory Services, LLC with notifications on news.